Bacterial Vaginosis Therapeutic
Bacterial Vaginosis (BV)
PreclinicalActive
Key Facts
About Matrubials
Matrubials is a private, preclinical-stage biotech spin-off from UC Davis, founded in 2016 and based in San Diego, CA. The company leverages an AI-enabled platform to discover and develop antimicrobial peptides derived from milk, aiming to provide selective and safe alternatives to traditional antibiotics. Its lead program targets Bacterial Vaginosis (BV), a condition with significant unmet need and long-term health complications for women. Matrubials represents a novel approach to infectious disease by mining nature's evolutionary solutions for new therapeutic candidates.
View full company profileTherapeutic Areas
Other Bacterial Vaginosis (BV) Drugs
| Drug | Company | Phase |
|---|---|---|
| DARE-BV1 | Dare Bioscience | Phase 2b |